theMednetRegister

Nephrology

Gastroenterology   

Questions discussed in this category

Would you consider anti-IL-5 therapy (mepolizumab or benralizumab) to either prevent or treat the more severe manifestations of eosinophilic granulomatosis with polyangiitis, such as "infiltrative" (e.g., cardiomyopathy, pulmonary infiltrates, or gastroenteritis) or "vasculitic" (e.g., neuropathy, palpable purpura, or glomerulonephritis)?
2 Answers available
How do you balance the need for diuretics from a volume perspective (Ex: ascites, edema) in decompensated cirrhotic patients and progressive renal dysfunction?
Do you opt for "accepting" a higher creatinine and worsening renal dysfunction for more euvolemia? How would this change your practice if a patient wa...
1 Answer available
When giving albumin challenge, for acute kidney injury with suspected hepatorenal syndrome, do you administer a single dose daily or split the dose of albumin?
1 Answer available
Do you avoid peritoneal dialysis in cirrhotic patients with ascites?
3 Answers available
Is there a serum ammonium level for which you recommend initiation of dialysis in a patient with hepatic encephalopathy?
3 Answers available
Do you avoid terlipressin for patients with hepatorenal syndrome who have an elevated bilirubin level?
2 Answers available
How do you approach the management of a patient with an ileostomy who has recurrent prerenal AKI episodes that improve with IV fluids but worsen with each attempt to transition to oral fluids alone?
1 Answer available
Do you take any special considerations for a patient with ESKD who has an ileostomy/colostomy and wishes to start peritoneal dialysis?
1 Answer available
How do you counsel patients who experience diarrhea from mycophenolate mofetil (Cellcept)?
Do you generally recommend anti-diarrheals, dietary modifications, or consider this an unacceptable side effect and move to other therapies? 
2 Answers available
Do you avoid terlipressin for patients with hepatorenal syndrome who have a serum sodium level less than 125 mEq/L?
2 Answers available
What is your treatment algorithm for management of retroperitoneal fibrosis that does not respond to high-dose glucocorticoids?
1 Answer available


Papers discussed in this category

Therapeutic drug monitoring, 2022 Jun 01
Drug-Drug Interactions Between Mycophenolic Acid and Proton Pump Inhibitors: A Systematic Review and Meta-Analysis.
The New England journal of medicine, 2021 Mar 04
Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome.
Clinical journal of the American Society of Nephrology : CJASN, 2023 Oct 17
How We Treat Hyperammonemia in Acute Liver Failure.
Medicine, 2016 Jan
Peritoneal Dialysis is Associated With A Better Survival in Cirrhotic Patients With Chronic Kidney Disease.
Clinical nephrology, 2011 Oct
Outcome of peritoneal dialysis in cirrhotic patients with end-stage renal disease: a 24-years' experience in Taiwan.
The American journal of medicine, 1992 Jul
Peritoneal dialysis in end-stage renal disease patients with preexisting chronic liver disease and ascites.
American journal of kidney diseases : the official journal of the National Kidney Foundation, 2002 Jul
Outcome of peritoneal dialysis in cirrhotic patients with chronic renal failure.
The New England journal of medicine, 2021 Mar 04
A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis.
Annals of internal medicine, 2025 Jul 29
Rituximab Versus Conventional Therapy for Remission Induction in Eosinophilic Granulomatosis With Polyangiitis : A Randomized Controlled Trial.

Related Topics in Nephrology

Copyright © 2025 theMednet
All Rights Reserved.